{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:26:22Z","timestamp":1791332782186,"version":"4.3.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":43,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Key Technologies R&D Program of China","award":["No. 2021YFC2500700"],"award-info":[{"award-number":["No. 2021YFC2500700"]}]},{"name":"National High Level Hospital Clinical Research Funding","award":["No. 2022- NHLHCRF-LX-01-0104"],"award-info":[{"award-number":["No. 2022- NHLHCRF-LX-01-0104"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"DOI":"10.1186\/s12931-026-03573-x","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T03:57:09Z","timestamp":1770868629000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Serum CA125 is independently associated with adverse outcomes in primary Sj\u00f6gren\u2019s syndrome-associated interstitial lung disease: a prospective multicenter cohort study"],"prefix":"10.1186","volume":"27","author":[{"given":"Wenyan","family":"Meng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaping","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,12]]},"reference":[{"key":"3573_CR1","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.3390\/jcm12072586","volume":"12","author":"O Berardicurti","year":"2023","unstructured":"Berardicurti O, Marino A, Genovali I, et al. Interstitial lung disease and pulmonary damage in primary Sj\u00f6gren\u2019s syndrome: A systematic review and Meta-Analysis. J Clin Med. 2023;12:2586.","journal-title":"J Clin Med"},{"key":"3573_CR2","doi-asserted-by":"publisher","first-page":"e32952","DOI":"10.1097\/MD.0000000000032952","volume":"102","author":"X Dong","year":"2023","unstructured":"Dong X, Gao Y, Li M, et al. Characteristics of chest HRCT and pulmonary function tests in elderly-onset primary Sj\u00f6gren syndrome with interstitial lung disease. Med (Baltim). 2023;102:e32952.","journal-title":"Med (Baltim)"},{"key":"3573_CR3","doi-asserted-by":"publisher","first-page":"12827","DOI":"10.1038\/s41598-021-92024-2","volume":"11","author":"YJ Kim","year":"2021","unstructured":"Kim YJ, Choe J, Kim HJ, Song JW. Long-term clinical course and outcome in patients with primary Sj\u00f6gren syndrome-associated interstitial lung disease. Sci Rep. 2021;11:12827.","journal-title":"Sci Rep"},{"key":"3573_CR4","doi-asserted-by":"publisher","first-page":"L303","DOI":"10.1152\/ajplung.00222.2023","volume":"326","author":"C Ebert","year":"2024","unstructured":"Ebert C, Walsh AM, Sereda L, et al. Circulating biomarker analyses in a longitudinal cohort of patients with IPF. Am J Physiol Lung Cell Mol Physiol. 2024;326:L303\u201312.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"3573_CR5","doi-asserted-by":"crossref","unstructured":"Parker MJS, Jee AS, Hansen D et al. Multiple serum biomarkers associate with mortality and interstitial lung disease progression in systemic sclerosis. Rheumatol Oxf Engl. 2024;keae110.","DOI":"10.1093\/rheumatology\/keae110"},{"key":"3573_CR6","doi-asserted-by":"publisher","first-page":"1098602","DOI":"10.3389\/fimmu.2023.1098602","volume":"14","author":"A Zhou","year":"2023","unstructured":"Zhou A, Tang H, Peng W, et al. KL-6 levels in the connective tissue disease population: typical values and potential confounders-a retrospective, real-world study. Front Immunol. 2023;14:1098602.","journal-title":"Front Immunol"},{"key":"3573_CR7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s42358-022-00269-w","volume":"62","author":"C Lv","year":"2022","unstructured":"Lv C, Zhang Q, Tang P, Guo L, Ding Q, Serum. MMP-9, SP-D, and VEGF levels reflect the severity of connective tissue disease-associated interstitial lung diseases. Adv Rheumatol Lond Engl. 2022;62:37.","journal-title":"Adv Rheumatol Lond Engl"},{"key":"3573_CR8","doi-asserted-by":"publisher","first-page":"16702","DOI":"10.1038\/s41598-022-20683-w","volume":"12","author":"BS Kwon","year":"2022","unstructured":"Kwon BS, Kim ES, Lim SY, et al. The significance of elevated tumor markers among patients with interstitial lung diseases. Sci Rep. 2022;12:16702.","journal-title":"Sci Rep"},{"key":"3573_CR9","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1007\/s10067-022-06089-z","volume":"41","author":"Q Wang","year":"2022","unstructured":"Wang Q, Gao C, Zhang C, et al. Tumor markers are associated with rapidly progressive interstitial lung disease in adult-dermatomyositis. Clin Rheumatol. 2022;41:1731\u20139.","journal-title":"Clin Rheumatol"},{"key":"3573_CR10","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s40744-021-00288-x","volume":"8","author":"M Zheng","year":"2021","unstructured":"Zheng M, Lou A, Zhang H, et al. Serum KL-6, CA19-9, CA125 and CEA are diagnostic biomarkers for rheumatoid Arthritis-Associated interstitial lung disease in the Chinese population. Rheumatol Ther. 2021;8:517\u201327.","journal-title":"Rheumatol Ther"},{"key":"3573_CR11","doi-asserted-by":"publisher","first-page":"27371","DOI":"10.1074\/jbc.M103554200","volume":"276","author":"BW Yin","year":"2001","unstructured":"Yin BW, Lloyd KO. Molecular cloning of the CA125 ovarian cancer antigen: identification as a new mucin, MUC16. J Biol Chem. 2001;276:27371\u20135.","journal-title":"J Biol Chem"},{"key":"3573_CR12","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1158\/1940-6207.CAPR-11-0378","volume":"4","author":"O Dorigo","year":"2011","unstructured":"Dorigo O, Berek JS. Personalizing CA125 levels for ovarian cancer screening. Cancer Prev Res Phila Pa. 2011;4:1356\u20139.","journal-title":"Cancer Prev Res Phila Pa"},{"key":"3573_CR13","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1016\/j.biocel.2007.05.013","volume":"39","author":"JR Davies","year":"2007","unstructured":"Davies JR, Kirkham S, Svitacheva N, Thornton DJ, Carlstedt I. MUC16 is produced in tracheal surface epithelium and submucosal glands and is present in secretions from normal human airway and cultured bronchial epithelial cells. Int J Biochem Cell Biol. 2007;39:1943\u201354.","journal-title":"Int J Biochem Cell Biol"},{"key":"3573_CR14","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1006\/gyno.2000.5776","volume":"77","author":"A Sevinc","year":"2000","unstructured":"Sevinc A, Buyukberber S, Sari R, et al. Elevated serum CA-125 levels in Hemodialysis patients with peritoneal, pleural, or pericardial fluids. Gynecol Oncol. 2000;77:254\u20137.","journal-title":"Gynecol Oncol"},{"key":"3573_CR15","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1002\/ejhf.2295","volume":"23","author":"J N\u00fa\u00f1ez","year":"2021","unstructured":"N\u00fa\u00f1ez J, de la Espriella R, Mi\u00f1ana G, et al. Antigen carbohydrate 125 as a biomarker in heart failure: a narrative review. Eur J Heart Fail. 2021;23:1445\u201357.","journal-title":"Eur J Heart Fail"},{"key":"3573_CR16","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/S2213-2600(17)30430-7","volume":"5","author":"TM Maher","year":"2017","unstructured":"Maher TM, Oballa E, Simpson JK, et al. An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort study. Lancet Respir Med. 2017;5:946\u201355.","journal-title":"Lancet Respir Med"},{"key":"3573_CR17","first-page":"587","volume":"34","author":"T Wang","year":"2016","unstructured":"Wang T, Zheng XJ, Ji YL, Liang ZA, Liang BM. Tumour markers in rheumatoid arthritis-associated interstitial lung disease. Clin Exp Rheumatol. 2016;34:587\u201391.","journal-title":"Clin Exp Rheumatol"},{"key":"3573_CR18","doi-asserted-by":"publisher","first-page":"4926","DOI":"10.3390\/jcm12154926","volume":"12","author":"F Wei","year":"2023","unstructured":"Wei F, Zhang X, Yang S, et al. Evaluation of the clinical value of KL-6 and tumor markers in primary Sj\u00f6gren\u2019s syndrome complicated with interstitial lung disease. J Clin Med. 2023;12:4926.","journal-title":"J Clin Med"},{"key":"3573_CR19","doi-asserted-by":"publisher","first-page":"e036809","DOI":"10.1136\/bmjopen-2020-036809","volume":"10","author":"B Xie","year":"2020","unstructured":"Xie B, Ren Y, Geng J, et al. Idiopathic pulmonary fibrosis registry China study (PORTRAY): protocol for a prospective, multicentre registry study. BMJ Open. 2020;10:e036809.","journal-title":"BMJ Open"},{"key":"3573_CR20","doi-asserted-by":"publisher","first-page":"01049","DOI":"10.1183\/23120541.01049-2024","volume":"11","author":"W Meng","year":"2025","unstructured":"Meng W, Zhang X, Zhang S, et al. Development and external validation of a model for lung transplantation-free survival prediction of primary Sj\u00f6gren syndrome-associated interstitial lung disease: a prospective cohort study. ERJ Open Res. 2025;11:01049\u20132024.","journal-title":"ERJ Open Res"},{"issue":"Suppl 5","key":"3573_CR21","first-page":"v1","volume":"63","author":"B Bradley","year":"2008","unstructured":"Bradley B, Branley HM, Egan JJ, et al. Interstitial lung disease guideline: the British thoracic society in collaboration with the thoracic society of Australia and new Zealand and the Irish thoracic society. Thorax. 2008;63(Suppl 5):v1\u201358.","journal-title":"Thorax"},{"key":"3573_CR22","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1164\/ajrccm.165.2.ats01","volume":"165","author":"American Thoracic Society, European Respiratory Society. American Thoracic Society\/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias","year":"2002","unstructured":"American Thoracic Society, European Respiratory Society. American Thoracic Society\/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American thoracic society (ATS), and the European respiratory society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS executive Committee, June 2001. Am J Respir Crit Care Med. 2002;165:277\u2013304.","journal-title":"Am J Respir Crit Care Med"},{"key":"3573_CR23","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","volume":"188","author":"WD Travis","year":"2013","unstructured":"Travis WD, Costabel U, Hansell DM, et al. An official American thoracic society\/European respiratory society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013;188:733\u201348.","journal-title":"Am J Respir Crit Care Med"},{"key":"3573_CR24","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1136\/ard.61.6.554","volume":"61","author":"C Vitali","year":"2002","unstructured":"Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sj\u00f6gren\u2019s syndrome: a revised version of the European criteria proposed by the American-European consensus group. Ann Rheum Dis. 2002;61:554\u20138.","journal-title":"Ann Rheum Dis"},{"key":"3573_CR25","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/art.39859","volume":"69","author":"CH Shiboski","year":"2017","unstructured":"Shiboski CH, Shiboski SC, Seror R, et al. 2016 American college of Rheumatology\/European league against rheumatism classification criteria for primary Sj\u00f6gren\u2019s syndrome: A consensus and Data-Driven methodology involving three international patient cohorts. Arthritis Rheumatol Hoboken NJ. 2017;69:35\u201345.","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"key":"3573_CR26","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.1164\/rccm.201908-1590ST","volume":"200","author":"BL Graham","year":"2019","unstructured":"Graham BL, Steenbruggen I, Miller MR, et al. Standardization of spirometry 2019 Update. An official American thoracic society and European respiratory society technical statement. Am J Respir Crit Care Med. 2019;200:e70\u201388.","journal-title":"Am J Respir Crit Care Med"},{"key":"3573_CR27","doi-asserted-by":"publisher","first-page":"1600016","DOI":"10.1183\/13993003.00016-2016","volume":"49","author":"BL Graham","year":"2017","unstructured":"Graham BL, Brusasco V, Burgos F, et al. 2017 ERS\/ATS standards for single-breath carbon monoxide uptake in the lung. Eur Respir J. 2017;49:1600016.","journal-title":"Eur Respir J"},{"key":"3573_CR28","first-page":"A1751","volume":"209","author":"W Meng","year":"2024","unstructured":"Meng W, Chen X, Xie B, Yang X, Dai H, Wang C. Fibrotic risk factors in primary sjogren\u2019s Syndrome-associated interstitial lung disease: A observational cohort study [abstract]. Am J Respir Crit Care Med. 2024;209:A1751.","journal-title":"Am J Respir Crit Care Med"},{"key":"3573_CR29","doi-asserted-by":"publisher","first-page":"204062232094480","DOI":"10.1177\/2040622320944802","volume":"11","author":"L Shi","year":"2020","unstructured":"Shi L, Han XL, Guo HX, et al. Increases in tumor markers are associated with primary Sj\u00f6gren\u2019s syndrome-associated interstitial lung disease. Ther Adv Chronic Dis. 2020;11:2040622320944802.","journal-title":"Ther Adv Chronic Dis"},{"key":"3573_CR30","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.2147\/IJGM.S310917","volume":"14","author":"Y Bao","year":"2021","unstructured":"Bao Y, Zhang W, Shi D, et al. Correlation between serum tumor marker levels and connective tissue disease-Related interstitial lung disease. Int J Gen Med. 2021;14:2553\u201360.","journal-title":"Int J Gen Med"},{"key":"3573_CR31","doi-asserted-by":"publisher","first-page":"e100393","DOI":"10.1371\/journal.pone.0100393","volume":"9","author":"IK Gipson","year":"2014","unstructured":"Gipson IK, Spurr-Michaud S, Tisdale A, Menon BB. Comparison of the transmembrane mucins MUC1 and MUC16 in epithelial barrier function. PLoS ONE. 2014;9:e100393.","journal-title":"PLoS ONE"},{"key":"3573_CR32","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1038\/onc.2010.87","volume":"29","author":"S Bafna","year":"2010","unstructured":"Bafna S, Kaur S, Batra SK. Membrane-bound mucins: the mechanistic basis for alterations in the growth and survival of cancer cells. Oncogene. 2010;29:2893\u2013904.","journal-title":"Oncogene"},{"key":"3573_CR33","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1111\/resp.12317","volume":"19","author":"H Dai","year":"2014","unstructured":"Dai H, Liu J, Liang L, et al. Increased lung cancer risk in patients with interstitial lung disease and elevated CEA and CA125 serum tumour markers. Respirol Carlton Vic. 2014;19:707\u201313.","journal-title":"Respirol Carlton Vic"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-026-03573-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-026-03573-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-026-03573-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T12:40:55Z","timestamp":1774615255000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12931-026-03573-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,12]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3573"],"URL":"https:\/\/doi.org\/10.1186\/s12931-026-03573-x","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,12]]},"assertion":[{"value":"13 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by Institutional Ethics Committee of Beijing Chaoyang Hospital (ethics approval number 2019-123-K85-1) and China-Japan Friendship Hospital, Beijing, China (ethics approval number 2017-25-1). Written informed consent was obtained from all patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"150"}}